Drugs / CT-P51
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06939595 | Jan 2025 → Feb 2027 expected | non-small cell lung carcinoma | Celltrion | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CT-P51 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06939595 ↗ |